Healthcare Realty Trust Inc (HR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q3 '21: 136.6M Q4 '21: 136.4M Q1 '22: 142.9M Q2 '22: 145.3M Q3 '22: 306.4M Q4 '22: 338.1M Q1 '23: 332.9M Q2 '23: 338.1M Q3 '23: 342.3M Q4 '23: 330.4M Q1 '24: 326.8M Q2 '24: 316.3M Q3 '24: 315.4M Q4 '24: 309.8M Q1 '25: 299M Q2 '25: 297.5M Q3 '25: 297.8M Q4 '25: 286.3M Q1 '26: 279M Q2 '26: 281.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 15M 30M 45M Q4 '13: 15.1M Q1 '14: 19.5M Q2 '14: 18.2M Q3 '14: 22.5M Q4 '14: 22.9M Q1 '15: 23.3M Q2 '15: 23M Q3 '15: 23.2M Q4 '15: 24.1M Q1 '16: 27.5M Q2 '16: 24.6M Q3 '16: 25.2M Q4 '16: 24.6M Q1 '17: 29.6M Q2 '17: 22.4M Q3 '17: 40.6M Q4 '17: 31.1M Q1 '18: 35.7M Q2 '18: 41.6M Q3 '18: 35.4M Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q2 '21: 23.1M Q3 '21: -2.1M Q4 '21: 21.6M Q1 '22: 42.2M Q2 '22: 6.1M Q3 '22: 28.3M Q1 '23: -87.1M Q2 '23: -82.8M Q3 '23: -67.8M Q4 '23: -40.5M Q1 '24: -310.8M Q2 '24: -143.8M Q3 '24: -93M Q4 '24: -106.8M Q1 '25: -44.9M Q2 '25: -157.9M Q3 '25: -57.7M Q4 '25: 14.4M Q1 '26: -56K Q2 '26: -43.5M Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 70M 140M 210M Q3 '21: 64.6M Q4 '21: 62.4M Q1 '22: 43.8M Q2 '22: 70.3M Q3 '22: 12.5M Q4 '22: 146.1M Q1 '23: 69.2M Q2 '23: 185.1M Q3 '23: 118.2M Q4 '23: 127.3M Q1 '24: 76.2M Q2 '24: 168.2M Q3 '24: 119.3M Q4 '24: 138M Q1 '25: 47.8M Q2 '25: 163.2M Q3 '25: 113.8M Q4 '25: 132.3M Q1 '26: 52.9M Q2 '26: 142.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-60M 0 60M 120M 180M Q3 '21: 36.8M Q4 '21: 31.3M Q1 '22: 20.4M Q2 '22: 48M Q3 '22: -39.6M Q4 '22: 80.3M Q1 '23: 9M Q2 '23: 151.3M Q3 '23: 117.6M Q4 '23: 53.2M Q1 '24: 25.8M Q2 '24: 100.8M Q3 '24: 50.3M Q4 '24: 75.8M Q1 '25: -21.3M Q2 '25: 77.6M Q3 '25: 24.9M Q4 '25: 45.8M Q1 '26: -8.3M Q2 '26: 72.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 220.6M Q2 '20: 222.1M Q3 '20: 218.5M Q1 '21: 222.3M Q2 '21: 142M Q3 '21: 143.8M Q1 '22: 149.1M Q2 '22: 149.7M Q3 '22: 332M Q1 '23: 378.8M Q2 '23: 378.9M Q3 '23: 378.9M Q1 '24: 379.5M Q2 '24: 372.5M Q3 '24: 359M Q1 '25: 349.5M Q2 '25: 349.6M Q3 '25: 350M Q1 '26: 347.4M Q2 '26: 342.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '20: 0.15 Q4 '20: 0.52 Q1 '21: 0.54 Q2 '21: 0.64 Q3 '21: 0.65 Q4 '21: 0.38 Q1 '22: 0.56 Q2 '22: 0.44 Q3 '22: 0.54 Q4 '23: -0.74 Q1 '24: -1.33 Q2 '24: -1.50 Q3 '24: -1.58 Q4 '24: -1.79 Q1 '25: -1.10 Q2 '25: -1.16 Q3 '25: -1.07 Q4 '25: -0.71 Q1 '26: -0.58 Q2 '26: -0.26 Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.